PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
08-Aug-2025 Faron Announces Extension to its Key Patent Family around Bexmarilimab and Targeting Clever-1 in Cancers with a New US Patent Granted ACCESS Newswire
07-Aug-2025 AI-Powered Transformation Provides Immediate ROI and Drives Hospital C-Suite Innovation With 8 Key Benefits, Black Book Survey Reports ACCESS Newswire
07-Aug-2025 eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST ACCESS Newswire
07-Aug-2025 RETRANSMISSION: Skineez(R) Debuts First-Ever Reversible Medical Grade Compression - A Game-Changer Made in the USA, Defying Tariffs and Redefining Retail Wellness ACCESS Newswire
07-Aug-2025 Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results ACCESS Newswire
07-Aug-2025 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025 ACCESS Newswire
07-Aug-2025 Skineez(R) Launches First-Ever Reversible Medical Grade Compression Sock-Made in the USA ACCESS Newswire
07-Aug-2025 StratifyMDX Announces Meraki ACCESS Newswire
07-Aug-2025 Sinceri Senior Living Adds Six Communities to Expanding Footprint Through Strategic Partnership With National Health Investors ACCESS Newswire
07-Aug-2025 Alta AI Debuts New 3D Perio Index Tool That Drives SRP Acceptance ACCESS Newswire
07-Aug-2025 Optical Genome Mapping Market Set to Reach USD 772.7 Million by 2032, Riding High on Genomic Innovations and Research Demand Acumen Research and Consulting
07-Aug-2025 Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction ACCESS Newswire
07-Aug-2025 Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners ACCESS Newswire
07-Aug-2025 Smile Digital Health Maintains Key Certifications in Security, Privacy, and Compliance ACCESS Newswire
07-Aug-2025 Massachusetts Cannabis Contamination Crisis Exposes Federal Negligence While DEA Targets Science, Not Safety ACCESS Newswire
07-Aug-2025 Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Advanced Amortisation of the First Tranche Bonds ACCESS Newswire
06-Aug-2025 Viemed Healthcare Announces Second Quarter 2025 Financial Results ACCESS Newswire
06-Aug-2025 Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth ACCESS Newswire
06-Aug-2025 NHI Issues Investor Update ACCESS Newswire
06-Aug-2025 NHI Announces Increase for the Third Quarter 2025 Dividend ACCESS Newswire